- Markets
- Healthcare
- KRSNAA
KRSNAA
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
India's Krsnaa Diagnostics rises after Q2 profit growth
** Shares of Krsnaa Diagnostics Ltd KRSN.NS rise as much as 7.8% to 845 rupees
** Diagnostic services co reports Q2 consol net profit rise of 87% y/y at ~196 mln rupees; rev ~20% higher
** Says, rev growth in the first half of FY2025 was driven by higher patient volume and tests counts amid competitive pricing
** More than 142,000 shares traded as of 10:42 a.m. IST, vs their 30-day moving avg of 128,154 shares
** KRSN last up 4.1%, adding to YTD gains of 15.6%
(Reporting by Meenakshi Maidas in Bengaluru)
(([email protected];))
** Shares of Krsnaa Diagnostics Ltd KRSN.NS rise as much as 7.8% to 845 rupees
** Diagnostic services co reports Q2 consol net profit rise of 87% y/y at ~196 mln rupees; rev ~20% higher
** Says, rev growth in the first half of FY2025 was driven by higher patient volume and tests counts amid competitive pricing
** More than 142,000 shares traded as of 10:42 a.m. IST, vs their 30-day moving avg of 128,154 shares
** KRSN last up 4.1%, adding to YTD gains of 15.6%
(Reporting by Meenakshi Maidas in Bengaluru)
(([email protected];))
Krsnaa Diagnostics Sept-Quarter Consol Net Profit 196 Million Rupees
Oct 25 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:
SEPT-QUARTER CONSOL NET PROFIT 196 MILLION RUPEES
SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 1.86 BILLION RUPEES
Further company coverage: KRSN.NS
(([email protected];))
Oct 25 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:
SEPT-QUARTER CONSOL NET PROFIT 196 MILLION RUPEES
SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 1.86 BILLION RUPEES
Further company coverage: KRSN.NS
(([email protected];))
India's Krsnaa Diagnostics jumps on approving Apulki Healthcare stake purchase
** Shares of Krsnaa Diagnostics KRSN.NS up 4.4% to 875 rupees, log their second-biggest intraday pct gain in two weeks
** Diagnostic services provider approves acquisition of 23.53% stake in equity shares of Apulki Healthcare
** Co did not disclose the cost of acquisition
** Stock up 23% YTD
(Reporting by Aleef Jahan in Bengaluru)
** Shares of Krsnaa Diagnostics KRSN.NS up 4.4% to 875 rupees, log their second-biggest intraday pct gain in two weeks
** Diagnostic services provider approves acquisition of 23.53% stake in equity shares of Apulki Healthcare
** Co did not disclose the cost of acquisition
** Stock up 23% YTD
(Reporting by Aleef Jahan in Bengaluru)
Krsnaa Diagnostics Approved Investment In Apulki Healthcare
Sept 25 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:
APPROVED INVESTMENT IN APULKI HEALTHCARE
CO SHALL ACQUIRE 23.53% OF STAKE IN APULKI
Source text for Eikon: ID:nNSE1x2s1G
Further company coverage: KRSN.NS
(([email protected];;))
Sept 25 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:
APPROVED INVESTMENT IN APULKI HEALTHCARE
CO SHALL ACQUIRE 23.53% OF STAKE IN APULKI
Source text for Eikon: ID:nNSE1x2s1G
Further company coverage: KRSN.NS
(([email protected];;))
India's Krsna Diagnostics gains on strong Q1 results
** Shares of Krsna Diagnostics KRSN.NS up ~ 5% at 672.70 rupees
** Co on Tuesday reported 24% Y/Y surge in Q1 profit after tax, while rev rose 22%
** Stk down 6.3% YTD, biggest drag among diagnostic stocks
** Peers Vijaya Diagnostic VIJA.NS up 18% YTD, Thyrocare THYO.NS up ~ 21%, Metropolis Health METP.NS up 23%, Dr Lal Path DLPA.NS up 23%
** KRSN, Thyrocare "strong buy" rated on average; METP, DLPA "hold" rated, while VIJA "buy" rated - LSEG
(Reporting by Sethuraman NR in Bengaluru)
(([email protected]; (+91 9945291420); Reuters Messaging: [email protected]))
** Shares of Krsna Diagnostics KRSN.NS up ~ 5% at 672.70 rupees
** Co on Tuesday reported 24% Y/Y surge in Q1 profit after tax, while rev rose 22%
** Stk down 6.3% YTD, biggest drag among diagnostic stocks
** Peers Vijaya Diagnostic VIJA.NS up 18% YTD, Thyrocare THYO.NS up ~ 21%, Metropolis Health METP.NS up 23%, Dr Lal Path DLPA.NS up 23%
** KRSN, Thyrocare "strong buy" rated on average; METP, DLPA "hold" rated, while VIJA "buy" rated - LSEG
(Reporting by Sethuraman NR in Bengaluru)
(([email protected]; (+91 9945291420); Reuters Messaging: [email protected]))
Krsnaa Diagnostics June-Quarter Consol Net Profit 179.2 Mln Rupees
Aug 6 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:
KRSNAA DIAGNOSTICS JUNE-QUARTER CONSOL NET PROFIT 179.2 MILLION RUPEES
KRSNAA DIAGNOSTICS JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 1.70 BILLION RUPEES
Source text for Eikon: ID:nNSE1YFs5m
Further company coverage: KRSN.NS
(([email protected];))
Aug 6 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:
KRSNAA DIAGNOSTICS JUNE-QUARTER CONSOL NET PROFIT 179.2 MILLION RUPEES
KRSNAA DIAGNOSTICS JUNE-QUARTER CONSOL REVENUE FROM OPERATIONS 1.70 BILLION RUPEES
Source text for Eikon: ID:nNSE1YFs5m
Further company coverage: KRSN.NS
(([email protected];))
India's Krsnaa Diagnostics rises on new contract
BENGALURU, July 24 (Reuters) - ** Shares of Krsnaa Diagnostics KRSN.NS rise 4.7% to 678.4 rupees apiece
** Rise after the diagnostic services provider signs contract with Madhya Pradesh government to set up, operate, manage and maintain MRI scan machines in five hospitals in the state
** KRSN has not disclosed the size of the contract in its exchange filing
** Shares of KRSN down about 4% in 2024 so far - Exchange data
(Reporting by Bharath Rajeswaran in Bengaluru)
(([email protected]; +91 9769003463;))
BENGALURU, July 24 (Reuters) - ** Shares of Krsnaa Diagnostics KRSN.NS rise 4.7% to 678.4 rupees apiece
** Rise after the diagnostic services provider signs contract with Madhya Pradesh government to set up, operate, manage and maintain MRI scan machines in five hospitals in the state
** KRSN has not disclosed the size of the contract in its exchange filing
** Shares of KRSN down about 4% in 2024 so far - Exchange data
(Reporting by Bharath Rajeswaran in Bengaluru)
(([email protected]; +91 9769003463;))
Krsnaa Diagnostics Signs Agreement For Providing MRI Services
July 23 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:
SIGNING OF AGREEMENT FOR PROVIDING MRI SERVICES
Source text for Eikon: ID:nNSE64F4GJ
Further company coverage: KRSN.NS
(([email protected];;))
July 23 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:
SIGNING OF AGREEMENT FOR PROVIDING MRI SERVICES
Source text for Eikon: ID:nNSE64F4GJ
Further company coverage: KRSN.NS
(([email protected];;))
Krsnaa Diagnostics Gets Tender from Bhabha Atomic Research Centre
July 4 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:
BHABHA ATOMIC RESEARCH CENTRE AWARDED TENDER TO CO
Source text for Eikon: ID:nBSE99X1vs
Further company coverage: KRSN.NS
(([email protected];))
July 4 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:
BHABHA ATOMIC RESEARCH CENTRE AWARDED TENDER TO CO
Source text for Eikon: ID:nBSE99X1vs
Further company coverage: KRSN.NS
(([email protected];))
India's Krsnaa Diagnostics rises after Systematix starts coverage with 'buy'
** Shares of Krsnaa Diagnostics KRSN.NS rise as much as 4.8% to 627.35 rupees, last up 4.1%
** Systematix Institutional Equities initiates coverage of pathology and radiology diagnostics services provider with "buy" rating and PT at 841 rupees
** The PT represents a 40.5% premium to stock's last close
** Over the last 5 years, KRSN clocked 34% and 25% CAGR in revenue and net earnings, respectively - Systematix
** Brokerage estimates 30% and 47% CAGR in KRSN's revenue and net earnings, respectively, over FY24-FY26, led by utilization of its recently set up diagnostic centers and opening of new centers
** KRSN's revenue is split 57:43 between radiology and pathology, and we expect the mix to slightly lean in favour of radiology in future - Systematix
(Reporting by Ashish Chandra in Bengaluru)
(([email protected] (+91 7982114624))
** Shares of Krsnaa Diagnostics KRSN.NS rise as much as 4.8% to 627.35 rupees, last up 4.1%
** Systematix Institutional Equities initiates coverage of pathology and radiology diagnostics services provider with "buy" rating and PT at 841 rupees
** The PT represents a 40.5% premium to stock's last close
** Over the last 5 years, KRSN clocked 34% and 25% CAGR in revenue and net earnings, respectively - Systematix
** Brokerage estimates 30% and 47% CAGR in KRSN's revenue and net earnings, respectively, over FY24-FY26, led by utilization of its recently set up diagnostic centers and opening of new centers
** KRSN's revenue is split 57:43 between radiology and pathology, and we expect the mix to slightly lean in favour of radiology in future - Systematix
(Reporting by Ashish Chandra in Bengaluru)
(([email protected] (+91 7982114624))
India's Krsnaa Diagnostics rises on agreement with state govt
** Shares of Krsnaa Diagnostics KRSN.NS up as much as 4% to 598 rupees; last up 2.7%
** Pathology and radiology diagnostics services provider said it has signed an agreement with the government of Maharashtra state to provide MRI and CT scan services in district hospitals
** More than 151,000 shares traded as of 1:33 p.m. IST, 1.7x the 30-day moving avg
** Including session's move, stock is down 16.3% YTD, while peer Vijaya Diagnostic Centre VIJA.NS is up 0.4%
(Reporting by Navamya Ganesh Acharya in Bengaluru)
(([email protected]; +91 8805175330 ;))
** Shares of Krsnaa Diagnostics KRSN.NS up as much as 4% to 598 rupees; last up 2.7%
** Pathology and radiology diagnostics services provider said it has signed an agreement with the government of Maharashtra state to provide MRI and CT scan services in district hospitals
** More than 151,000 shares traded as of 1:33 p.m. IST, 1.7x the 30-day moving avg
** Including session's move, stock is down 16.3% YTD, while peer Vijaya Diagnostic Centre VIJA.NS is up 0.4%
(Reporting by Navamya Ganesh Acharya in Bengaluru)
(([email protected]; +91 8805175330 ;))
Krsnaa Diagnostics Signed Agreement With Health Services And Mission Director, Government Of Maharashtra
May 1 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:
SIGNED AGREEMENT WITH HEALTH SERVICES AND MISSION DIRECTOR, GOVERNMENT OF MAHARASHTRA
AGREEMENT FOR PROVIDING MRI AND CT SCAN SERVICES IN MAHARASHTRA IN DISTRICT HOSPITALS UNDER AUTHORITY
Source text for Eikon: ID:nBSE4lgJ3D
Further company coverage: KRSN.NS
(([email protected];;))
May 1 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:
SIGNED AGREEMENT WITH HEALTH SERVICES AND MISSION DIRECTOR, GOVERNMENT OF MAHARASHTRA
AGREEMENT FOR PROVIDING MRI AND CT SCAN SERVICES IN MAHARASHTRA IN DISTRICT HOSPITALS UNDER AUTHORITY
Source text for Eikon: ID:nBSE4lgJ3D
Further company coverage: KRSN.NS
(([email protected];;))
Krsnaa Diagnostics Says Dy. Commissioner Of Income Tax, Pune Issued Assessment Order And Demand Notice
April 1 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:
DY. COMMISSIONER OF INCOME TAX, PUNE ISSUED ASSESSMENT ORDER AND DEMAND NOTICE
GETS TAX ORDER FOR DEMAND AT 196.3 MILLION RUPEES
Source text for Eikon: ID:nBSEbxx1xn
Further company coverage: KRSN.NS
(([email protected];))
April 1 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:
DY. COMMISSIONER OF INCOME TAX, PUNE ISSUED ASSESSMENT ORDER AND DEMAND NOTICE
GETS TAX ORDER FOR DEMAND AT 196.3 MILLION RUPEES
Source text for Eikon: ID:nBSEbxx1xn
Further company coverage: KRSN.NS
(([email protected];))
Krsnaa Diagnostics Receipt Of Certificate Of Accreditation From College Of American Pathologists
March 14 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:
KRSNAA DIAGNOSTICS LTD - RECEIPT OF CERTIFICATE OF ACCREDITATION FROM COLLEGE OF AMERICAN PATHOLOGISTS
Source text for Eikon: ID:nBSE7hkkLs
Further company coverage: KRSN.NS
(([email protected];))
March 14 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:
KRSNAA DIAGNOSTICS LTD - RECEIPT OF CERTIFICATE OF ACCREDITATION FROM COLLEGE OF AMERICAN PATHOLOGISTS
Source text for Eikon: ID:nBSE7hkkLs
Further company coverage: KRSN.NS
(([email protected];))
India's Krsnaa Diagnostics down after Q2 profit fall
** Shares of diagnostics services provider Krsnaa Diagnostics KRSN.NS fall as much as 7.7% to 663.25 rupees
** Stock sees biggest intraday pct loss since Sept. 12
** Co reported a near 32% fall in consolidated net profit of 105 mln rupees ($1.26 million)
** Total expenses rose nearly 37%, hit by input costs which rose more than two-fold
** More than 168,000 shares traded by 12:05 p.m. IST, vs 1.6x 30-day avg
** Stock currently down 3.8%, trimming YTD gains to 50%
($1 = 83.2110 Indian rupees)
(Reporting by Navamya Ganesh Acharya in Bengaluru)
(([email protected]; +91 8805175330 ;))
** Shares of diagnostics services provider Krsnaa Diagnostics KRSN.NS fall as much as 7.7% to 663.25 rupees
** Stock sees biggest intraday pct loss since Sept. 12
** Co reported a near 32% fall in consolidated net profit of 105 mln rupees ($1.26 million)
** Total expenses rose nearly 37%, hit by input costs which rose more than two-fold
** More than 168,000 shares traded by 12:05 p.m. IST, vs 1.6x 30-day avg
** Stock currently down 3.8%, trimming YTD gains to 50%
($1 = 83.2110 Indian rupees)
(Reporting by Navamya Ganesh Acharya in Bengaluru)
(([email protected]; +91 8805175330 ;))
India's Krsnaa Diagnostics Sept-Quarter Consol Net Profit Falls
Nov 3 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:
INDIA'S KRSNAA DIAGNOSTICS SEPT-QUARTER CONSOL NET PROFIT 105 MILLION RUPEES VERSUS 153.4 MILLION RUPEES
KRSNAA DIAGNOSTICS SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 1.55 BILLION RUPEES VERSUS 1.23 BILLION RUPEES
Source text for Eikon: ID:nBSE8TbxvV
Further company coverage: KRSN.NS
(([email protected];))
Nov 3 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:
INDIA'S KRSNAA DIAGNOSTICS SEPT-QUARTER CONSOL NET PROFIT 105 MILLION RUPEES VERSUS 153.4 MILLION RUPEES
KRSNAA DIAGNOSTICS SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 1.55 BILLION RUPEES VERSUS 1.23 BILLION RUPEES
Source text for Eikon: ID:nBSE8TbxvV
Further company coverage: KRSN.NS
(([email protected];))
JM Financial views robust execution for India's Krsnaa Diagnostics
** Shares of India's Krsnaa Diagnostics KRSN.NS up as much as 5.4% at 680 rupees, posting highest level since Feb 4, 2022
** Co seen rising for third consecutive session
** Confident of co's execution capabilities, believe sufficient scope for earnings upgrade, - brokerage JM Financial note
** KRSN'S guidance is overall better than we expected, says JM Financial; rates co "buy" with PT of 1,050 rupees
** Co shared its annual report with its shareholders on Sept. 2
** However, brokerage flags change in mix towards pathology, large-scale tender implementation could mean "subdued near term margin"
** More than 230,000 shares changed hands by 3:23 p.m. IST, 1.2x 30-day avg
** YTD stock has soared 47%
(Reporting by Hritam Mukherjee in Bengaluru)
(([email protected];))
** Shares of India's Krsnaa Diagnostics KRSN.NS up as much as 5.4% at 680 rupees, posting highest level since Feb 4, 2022
** Co seen rising for third consecutive session
** Confident of co's execution capabilities, believe sufficient scope for earnings upgrade, - brokerage JM Financial note
** KRSN'S guidance is overall better than we expected, says JM Financial; rates co "buy" with PT of 1,050 rupees
** Co shared its annual report with its shareholders on Sept. 2
** However, brokerage flags change in mix towards pathology, large-scale tender implementation could mean "subdued near term margin"
** More than 230,000 shares changed hands by 3:23 p.m. IST, 1.2x 30-day avg
** YTD stock has soared 47%
(Reporting by Hritam Mukherjee in Bengaluru)
(([email protected];))
India's Krsnaa Diagnostics climbs after upbeat guidance
** Shares of Krsnaa Diagnostics KRSN.NS rise as much as 8.59% to 573 rupees
** Stock up 17% in two sessions after the diagnostics services provider reiterates guidance for fiscal 2024
** KRSN expects revenue growth of 30-35%; sees 3 bln rupees revenue contribution from a recent Rajasthan contract in fiscal 2025
** Brokerage JM Financial reiterates "buy" and raises target price to 960 rupees from 930 rupees
** JM says confident of KRSN's strong execution and sees scope for stock re-rating
** Trading volume is 477,908 shares as of 2:16 p.m. IST, nearly thrice the 30-day avg - Refinitiv data
** Stock up ~23% this year
(Reporting by Bharath Rajeswaran in Bengaluru)
(([email protected]; +91 9769003463))
** Shares of Krsnaa Diagnostics KRSN.NS rise as much as 8.59% to 573 rupees
** Stock up 17% in two sessions after the diagnostics services provider reiterates guidance for fiscal 2024
** KRSN expects revenue growth of 30-35%; sees 3 bln rupees revenue contribution from a recent Rajasthan contract in fiscal 2025
** Brokerage JM Financial reiterates "buy" and raises target price to 960 rupees from 930 rupees
** JM says confident of KRSN's strong execution and sees scope for stock re-rating
** Trading volume is 477,908 shares as of 2:16 p.m. IST, nearly thrice the 30-day avg - Refinitiv data
** Stock up ~23% this year
(Reporting by Bharath Rajeswaran in Bengaluru)
(([email protected]; +91 9769003463))
Krsnaa Diagnostics Says Co And National Health Mission, Assam Has Signed Contract
July 28 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:
CO AND NATIONAL HEALTH MISSION, ASSAM HAS SIGNED CONTRACT
TENDER FOR ESTABLISHMENT, OPERATION, MAINTENANCE OF LABORATORY DIAGNOSTIC CENTRES
Source text for Eikon: ID:nBSE6pZqFv
Further company coverage: KRSN.NS
(([email protected];))
July 28 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:
CO AND NATIONAL HEALTH MISSION, ASSAM HAS SIGNED CONTRACT
TENDER FOR ESTABLISHMENT, OPERATION, MAINTENANCE OF LABORATORY DIAGNOSTIC CENTRES
Source text for Eikon: ID:nBSE6pZqFv
Further company coverage: KRSN.NS
(([email protected];))
India's Krsnaa Diagnostics falls on award cancellation for consortium
** Shares of diagnostic services provider Krsnaa Diagnostics KRSN.NS fall as much as 15.5% to 451.20 rupees, sharpest intraday pct loss since Oct 12, 2021
** Stock of KRSN hits lowest level since March 31, and on track for a seventh consecutive session of losses, if trend holds
** The National Health Mission in Rajasthan on Wednesday canceled letter of award for consortium of co with Telecommunications Consultants India TELO.NS nFWN39514B
** More than 306,000 shares change hands, 4.4x the 30-day avg, most active trading session since May 30
** Stock up 15.9% this year as of last close
(Reporting by Anisha Ajith in Bengaluru)
(([email protected];))
** Shares of diagnostic services provider Krsnaa Diagnostics KRSN.NS fall as much as 15.5% to 451.20 rupees, sharpest intraday pct loss since Oct 12, 2021
** Stock of KRSN hits lowest level since March 31, and on track for a seventh consecutive session of losses, if trend holds
** The National Health Mission in Rajasthan on Wednesday canceled letter of award for consortium of co with Telecommunications Consultants India TELO.NS nFWN39514B
** More than 306,000 shares change hands, 4.4x the 30-day avg, most active trading session since May 30
** Stock up 15.9% this year as of last close
(Reporting by Anisha Ajith in Bengaluru)
(([email protected];))
Krsnaa Diagnostics Says National Health Mission, Rajasthan Canceled LoA To Consortium Of Co With Telecommunications Consultants India
July 19 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:
NATIONAL HEALTH MISSION, RAJASTHAN CANCELED LOA TO CONSORTIUM OF CO WITH TELECOMMUNICATIONS CONSULTANTS INDIA
CO IN COLLABORATION WITH TELECOMMUNICATIONS CONSULTANTS INDIA TOOK LEGAL RECOURSE
Source text for Eikon: [ID:]
Further company coverage: KRSN.NS
(([email protected];))
July 19 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:
NATIONAL HEALTH MISSION, RAJASTHAN CANCELED LOA TO CONSORTIUM OF CO WITH TELECOMMUNICATIONS CONSULTANTS INDIA
CO IN COLLABORATION WITH TELECOMMUNICATIONS CONSULTANTS INDIA TOOK LEGAL RECOURSE
Source text for Eikon: [ID:]
Further company coverage: KRSN.NS
(([email protected];))
India's Krsnaa Diagnostics rises on bagging lab development contract in Assam
** Shares of diagnostic services provider Krsnaa Diagnostics Ltd KRSN.NS up as much as 3.9% to 589.95 rupees, their biggest intraday pct gain since June 12
** Co said it recieved letter of acceptance for emerging as L1 Bidder for tender from National Health Mission, Assam
** Tender for establishment, operation and maintenance of laboratory diagnostic centres in Assam
** KRSN is trading above its 50-, 100-, and 200-day simple moving averages, indicating bullish sentiment
** Stock hits highest since June 21
** About 28,033 shares change hands as of 11:36 a.m. IST, vs 0.3x 30-day average of 97,939 shares
** Stock up 23.2% YTD as of last close
(Reporting by Manvi Pant in Bengaluru)
(([email protected]; +918447554364;))
** Shares of diagnostic services provider Krsnaa Diagnostics Ltd KRSN.NS up as much as 3.9% to 589.95 rupees, their biggest intraday pct gain since June 12
** Co said it recieved letter of acceptance for emerging as L1 Bidder for tender from National Health Mission, Assam
** Tender for establishment, operation and maintenance of laboratory diagnostic centres in Assam
** KRSN is trading above its 50-, 100-, and 200-day simple moving averages, indicating bullish sentiment
** Stock hits highest since June 21
** About 28,033 shares change hands as of 11:36 a.m. IST, vs 0.3x 30-day average of 97,939 shares
** Stock up 23.2% YTD as of last close
(Reporting by Manvi Pant in Bengaluru)
(([email protected]; +918447554364;))
Krsnaa Diagnostics Gets Letter Of Acceptance For Emerging As L1 Bidder For Tender By National Health Mission, Assam
June 28 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:
GETS LETTER OF ACCEPTANCE FOR EMERGING AS L1 BIDDER FOR TENDER BY NATIONAL HEALTH MISSION, ASSAM
Source text for Eikon: ID:nBSE55P0HZ
Further company coverage: KRSN.NS
(([email protected];))
June 28 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:
GETS LETTER OF ACCEPTANCE FOR EMERGING AS L1 BIDDER FOR TENDER BY NATIONAL HEALTH MISSION, ASSAM
Source text for Eikon: ID:nBSE55P0HZ
Further company coverage: KRSN.NS
(([email protected];))
Krsnaa Diagnostics Says Commencement Of Diagnostics Center Under Uttar Pradesh Ct Scan Project
May 8 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:
COMMENCEMENT OF DIAGNOSTICS CENTER UNDER UTTAR PRADESH CT SCAN PROJECT
Source text for Eikon: [ID:]
Further company coverage: KRSN.NS
(([email protected];))
May 8 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:
COMMENCEMENT OF DIAGNOSTICS CENTER UNDER UTTAR PRADESH CT SCAN PROJECT
Source text for Eikon: [ID:]
Further company coverage: KRSN.NS
(([email protected];))
Krsnaa Diagnostics Qualified As L1 Bidder For Tender
May 1 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:
QUALIFIED AS L1 BIDDER FOR TENDER
TENDER ISSUED BY NATIONAL HEALTH MISSION, ASSAM ON PUBLIC PRIVATE PARTNERSHIP BASIS
Source text for Eikon: ID:nNSEbdWbfW
Further company coverage: KRSN.NS
(([email protected];))
May 1 (Reuters) - Krsnaa Diagnostics Ltd KRSN.NS:
QUALIFIED AS L1 BIDDER FOR TENDER
TENDER ISSUED BY NATIONAL HEALTH MISSION, ASSAM ON PUBLIC PRIVATE PARTNERSHIP BASIS
Source text for Eikon: ID:nNSEbdWbfW
Further company coverage: KRSN.NS
(([email protected];))
Events:
Dividend
Dividend
Dividend
More Small Cap Ideas
See similar 'Small' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Krsnaa Diagnostics do?
Krsnaa Diagnostics is a leading diagnostic chain in India, offering a comprehensive range of imaging and pathology services to healthcare institutions with a focus on efficiency and scalability.
Who are the competitors of Krsnaa Diagnostics?
Krsnaa Diagnostics major competitors are Vijaya Diagnostic, Thyrocare Tech., Vimta Labs, Nidan Labs. & Health, Metropolis Health., Dr. Lal Pathlabs. Market Cap of Krsnaa Diagnostics is ₹2,544 Crs. While the median market cap of its peers are ₹6,602 Crs.
Is Krsnaa Diagnostics financially stable compared to its competitors?
Krsnaa Diagnostics seems to be less financially stable compared to its competitors. Altman Z score of Krsnaa Diagnostics is 5.99 and is ranked 6 out of its 7 competitors.
Does Krsnaa Diagnostics pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Krsnaa Diagnostics latest dividend payout ratio is 14.2% and 3yr average dividend payout ratio is 13.19%
How has Krsnaa Diagnostics allocated its funds?
Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Accounts Receivable, Short Term Loans & Advances
How strong is Krsnaa Diagnostics balance sheet?
Balance sheet of Krsnaa Diagnostics is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Krsnaa Diagnostics improving?
The profit is oscillating. The profit of Krsnaa Diagnostics is ₹75.66 Crs for TTM, ₹56.84 Crs for Mar 2024 and ₹62.11 Crs for Mar 2023.
Is the debt of Krsnaa Diagnostics increasing or decreasing?
Yes, The debt of Krsnaa Diagnostics is increasing. Latest debt of Krsnaa Diagnostics is ₹106 Crs as of Sep-24. This is greater than Mar-24 when it was ₹54.03 Crs.
Is Krsnaa Diagnostics stock expensive?
Krsnaa Diagnostics is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA. Latest PE of Krsnaa Diagnostics is 33.62, while 3 year average PE is 27.44. Also latest EV/EBITDA of Krsnaa Diagnostics is 14.66 while 3yr average is 14.95.
Has the share price of Krsnaa Diagnostics grown faster than its competition?
Krsnaa Diagnostics has given better returns compared to its competitors. Krsnaa Diagnostics has grown at ~9.94% over the last 3yrs while peers have grown at a median rate of -1.0%
Is the promoter bullish about Krsnaa Diagnostics?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Krsnaa Diagnostics is 27.24% and last quarter promoter holding is 27.24%.
Are mutual funds buying/selling Krsnaa Diagnostics?
The mutual fund holding of Krsnaa Diagnostics is decreasing. The current mutual fund holding in Krsnaa Diagnostics is 9.36% while previous quarter holding is 9.82%.